Search

Home > GRACEcast Lung Cancer Video > Highlights in Lung Cancer, 2013: MEK Inhibitors for KRAS Mutation-Positive NSCLC (video)
Podcast: GRACEcast Lung Cancer Video
Episode:

Highlights in Lung Cancer, 2013: MEK Inhibitors for KRAS Mutation-Positive NSCLC (video)
Category: Science & Medicine
Duration: 00:05:27
Publish Date: 2013-03-29 23:46:42
Description:

Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, reviews exciting new data illustrating the potential benefits of the MEK inhibitor selumetinib in treating KRAS mutation-positive advanced non-small cell lung cancer.
Total Play: 0